Literature DB >> 32175225

Impact of paroxysmal versus non-paroxysmal atrial fibrillation on outcomes in patients undergoing transcatheter mitral valve repair.

Kishorbhai Gangani1, Haytham Alkhaimy2, Nikita Patil3, Kranthi Sitammagari4, Poonam Bhyan5, Sameer Arora6, John P Vavalle3.   

Abstract

BACKGROUND: To study the impact of type of atrial fibrillation on outcomes following transcatheter mitral valve repair. The development of atrial fibrillation (AF) in degenerative mitral regurgitation (MR) can be a sign of progression of MR and associated with adverse outcomes. However, the impact of type of AF in patients undergoing transcatheter mitral valve (MV) repair remains uncertain.
METHODS: Patients 18 years or older who underwent TMVR procedure in 2016 and had a concurrent ICD-10 diagnosis of either paroxysmal or non-paroxysmal AF were included from Nationwide Readmission Database (NRD). The association between type of AF and mortality, stroke, readmission (cardiovascular and non-cardiovascular readmissions) and composite outcome (mortality, inpatient stroke or 30-day readmissions) was analyzed using multivariable logistic regression. Statistical Analysis System (SAS) software 9.4 was used to conduct the analysis.
RESULTS: A total of 913 (weighted N=1,750) TMVR hospitalizations from NRD for year 2016 were included. Of these, 510 (weighted N=995) patients had non-paroxysmal AF and 403 (weighted N=755) had paroxysmal AF. Patients with non-paroxysmal AF were older than paroxysmal AF (82.53 vs. 81.27; P=0.0004). As compared to paroxysmal AF, those with non-paroxysmal AF had comparable odds of composite outcome of stroke, readmission, or mortality (OR 1.31; 95% CI: 0.77-2.23), as well as stroke (OR 0.43; 95% CI: 0.10-1.78), or mortality (OR 0.54; 95% CI: 0.21-1.37), in patients undergoing TMVR. Similarly, no differences were noted in the odds of cardiac readmissions (OR 1.38; 95% CI: 0.83-2.28), non-cardiac readmissions (OR 0.80; 95% CI: 0.49-1.32) and discharge to skilled nursing/short term care (OR 1.24; 95% CI: 0.66-2.36) in those with non-paroxysmal vs. paroxysmal AF.
CONCLUSIONS: Inpatient outcomes and readmissions were similar in patient with paroxysmal and non-paroxysmal atrial fibrillation in this study. Future studies exploring the effect of type of atrial fibrillation on long term outcomes are needed. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation (AF); mortality; paroxysmal; transcatheter mitral valve repair (TMVR)

Year:  2020        PMID: 32175225      PMCID: PMC7044103          DOI: 10.21037/cdt.2019.08.06

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  12 in total

1.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  J Am Coll Cardiol       Date:  2017-03-15       Impact factor: 24.094

2.  The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

Authors:  Sameer Arora; Sreekanth Vemulapalli; Amanda Stebbins; Cassandra J Ramm; Andrzej S Kosinski; Paul Sorajja; Jonathan P Piccini; Matthew A Cavender; John P Vavalle
Journal:  JACC Cardiovasc Interv       Date:  2019-03-25       Impact factor: 11.195

3.  Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation.

Authors:  Kosei Eguchi; Eiji Ohtaki; Takayoshi Matsumura; Kaoru Tanaka; Tetsuya Tohbaru; Nobuo Iguchi; Kazuhiko Misu; Ryuta Asano; Masatoshi Nagayama; Tetsuya Sumiyoshi; Hitoshi Kasegawa; Saichi Hosoda
Journal:  Eur Heart J       Date:  2005-04-21       Impact factor: 29.983

4.  Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report.

Authors:  Paul Sorajja; Sreekanth Vemulapalli; Ted Feldman; Michael Mack; David R Holmes; Amanda Stebbins; Saibal Kar; Vinod Thourani; Gorav Ailawadi
Journal:  J Am Coll Cardiol       Date:  2017-11-07       Impact factor: 24.094

5.  Percutaneous repair or surgery for mitral regurgitation.

Authors:  Ted Feldman; Elyse Foster; Donald D Glower; Donald G Glower; Saibal Kar; Michael J Rinaldi; Peter S Fail; Richard W Smalling; Robert Siegel; Geoffrey A Rose; Eric Engeron; Catalin Loghin; Alfredo Trento; Eric R Skipper; Tommy Fudge; George V Letsou; Joseph M Massaro; Laura Mauri
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

Review 6.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

7.  Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome.

Authors:  Francesco Grigioni; Jean-François Avierinos; Lieng H Ling; Christopher G Scott; Kent R Bailey; A Jamil Tajik; Robert L Frye; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

8.  The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation.

Authors:  Christos Alexiou; George Doukas; Mehmet Oc; Bahar Oc; Justiaan Swanevelder; Nilesh J Samani; Tomasz J Spyt
Journal:  Eur J Cardiothorac Surg       Date:  2007-02-05       Impact factor: 4.191

Review 9.  A proposal for new clinical concepts in the management of atrial fibrillation.

Authors:  A John Camm; Sana M Al-Khatib; Hugh Calkins; Jonathan L Halperin; Paulus Kirchhof; Gregory Y H Lip; Stanley Nattel; Jeremy Ruskin; Amitava Banerjee; Dan Blendea; Eduard Guasch; Matthew Needleman; Irina Savelieva; Juan Viles-Gonzalez; Eric S Williams
Journal:  Am Heart J       Date:  2012-08-03       Impact factor: 4.749

10.  Effect of Atrial Fibrillation and Mitral Valve Gradients on Response to Percutaneous Mitral Valve Repair With the MitraClip System.

Authors:  Maximilian Spieker; Katharina Hellhammer; Jens Spießhöfer; Stratis Katsianos; Jan Balzer; Tobias Zeus; Patrick Horn; Malte Kelm; Ralf Westenfeld
Journal:  Am J Cardiol       Date:  2018-07-17       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.